The Use of Andexanet Alfa Vs. Four-Factor Prothrombin Complex Concentrates in the Reversal of Life-Threatening Intracranial Hemorrhage

被引：0
|
作者：
Gatell, Vivian Irizarry [1 ]
Bacchus, Michael [2 ]
De Leo, Edward [1 ]
Zhang, Yang [3 ]
Lagasse, Carrie [4 ]
Khanna, Anna Y. [5 ]
Harris, Neil [6 ]
Zumberg, Marc S. [7 ]
机构：
[1] Univ Florida, Div Hematol & Oncol, Gainesville, FL USA
[2] Univ Florida, Coll Med, Gainesville, FL USA
[3] Univ Florida, Dept Med, Gainesville, FL USA
[4] Univ Florida, Dept Pharmacol, Gainesville, FL 32610 USA
[5] Univ Florida, Dept Neurol, Gainesville, FL USA
[6] Univ Florida, Gainesville, FL USA
[7] Univ Florida, Div Hematol Oncol, Gainesville, FL USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-167748
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5696 / 5697
页数：2
相关论文
共 50 条
  • [1] The use of andexanet alfa vs. 4-factor prothrombin complex concentrates in the setting of life-threatening intracranial hemorrhage
    Irizarry-Gatell, Vivian M.
    Bacchus, Michael W.
    De Leo, Edward K.
    Zhang, Yang
    Lagasse, Carrie A.
    Khanna, Anna Y.
    Harris, Neil S.
    Zumberg, Marc S.
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2024, 35 (03) : 94 - 100
  • [2] Co-administration of Four-Factor Prothrombin Complex Concentrate With Andexanet alfa for Reversal of Nontraumatic Intracranial Hemorrhage
    Pathan, Sophia
    [J]. HOSPITAL PHARMACY, 2024, 59 (04) : 394 - 406
  • [3] Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage
    Mark L. Vestal
    Kimberly Hodulik
    Jennifer Mando-Vandrick
    Michael L. James
    Thomas L. Ortel
    Matthew Fuller
    Maria Notini
    Mark Friedland
    Ian J. Welsby
    [J]. Journal of Thrombosis and Thrombolysis, 2022, 53 : 167 - 175
  • [4] Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage
    Vestal, Mark L.
    Hodulik, Kimberly
    Mando-Vandrick, Jennifer
    James, Michael L.
    Ortel, Thomas L.
    Fuller, Matthew
    Notini, Maria
    Friedland, Mark
    Welsby, Ian J.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 53 (01) : 167 - 175
  • [5] Four-factor prothrombin complex concentrate versus andexanet alfa for the reversal of traumatic brain injuries
    Sadek, Erin
    Curtiss, William
    Andrews, Jessica
    Hecht, Jason
    [J]. EMERGENCY MEDICINE JOURNAL, 2024, 41 (03) : 162 - 167
  • [6] Four-factor prothrombin complex concentrate versus andexanet alfa for direct oral anticoagulant reversal
    Koo, Soo Jin
    Hussain, Yunus
    Booth, Deborah Y.
    Desai, Payal
    Oh, Elly S.
    Rios, Jose
    Audley, Kristen
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2024, 64 (02) : 395 - 401
  • [7] Four-factor prothrombin complex concentrate administration after expanding intracranial hemorrhage status post administration of andexanet alfa
    Blackburn, Matthew
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 62 : 144.e1 - 144.e3
  • [8] Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages
    Pham, Haithuy
    Medford, Whitney Gibson
    Horst, Spencer
    Levesque, Melissa
    Ragoonanan, David
    Price, Christine
    Colbassani, Harold
    Piper, Keaton
    Chastain, Keith
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 55 : 38 - 44
  • [9] Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies
    Ferreira, Luan Oliveira
    Oldemburg, Ricardo Andres Leon
    Leitao Filho, Joao Monteiro
    Cerveira, Rodrigo Arcoverde
    Vasconcelos, Victoria Winkler
    da Costa, Giovana Escribano
    Rodrigues, Roseny dos Reis
    Lopes, Dielly Catrina Favacho
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [10] Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
    Rech, Megan A.
    Masic, Dalila
    Hammond, Drayton A.
    [J]. WESTERN JOURNAL OF EMERGENCY MEDICINE, 2021, 22 (02) : 163 - 169
12345